Clinical Trial

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes

Study acronym: GLYMETY
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 5, 2026 (before its estimated April 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
In clinical practice, women living with type 1 diabetes frequently report that insulin requirements change across the menstrual cycle. Consequently, glycemic fluctuations are observed. This phenomenon could be explained by a decrease in insulin sensitivity during the second half of the menstrual cycle (luteal phase). Overall, despite an important proportion of women reporting glycemic and/or insulin variations across the menstrual cycle, studies to date have involved small sample sizes, and have had inconsistent results. The objective of this study will be to study glycemic fluctuations across the menstrual cycle using CGM data, alongside insulin data, in a large sample of women.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-02-17; most recent amendment 2026-03-03.
Status change: Not Yet Recruiting → Recruiting 2022-07-26
Trial Details
NCT Number NCT05258292
Lead Sponsor Institut de Recherches Cliniques de Montreal
Conditions Type1diabetes
Enrollment 86 participants
Start Date 2022-05-02
Primary Completion 2026-04-01 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-05